Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 6Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Stomach Neoplasms 2Neoplasm Metastasis 2Melanoma 2Head and Neck Neoplasms 2Disease 2Colonic Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Vasculitis 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Osteomyelitis 1Nose Neoplasms 1Myelodysplastic Syndromes 1Multiple Pulmonary Nodules 1

Interventions

sargramostim 1Tomography, X-Ray Computed 1Salts 1Radionuclide Imaging 1Positron-Emission Tomography 1Moxibustion 1Magnetic Resonance Spectroscopy 1Ibuprofen 1Gemcitabine 1Fluorodeoxyglucose F18 1Fentanyl 1FPP(RGD)2 1Etoposide 1Endoscopic Mucosal Resection 1Electrocardiography 1Doxorubicin 1Doxepin 1Cisplatin 1Bevacizumab 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Esthesioneuroblastoma, Olfactory × Positron-Emission Tomography × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡